Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer

British Journal of Surgery

Volumn 97, Issue 11, 2010, Pages 1646-1652

  Moghaddam, Y ^a   Falzon, M ^a   Fulford, L ^a   Williams, N R ^b   Keshtgar, M R ^b,c  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; AXILLA; BREAST TUMOR; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; NOMOGRAM; PATHOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AREA UNDER CURVE; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NOMOGRAMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 78049400762     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7181     Document Type: Article

References (56)

1. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553. (Pubitemid 36951366)
2. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-946. (Pubitemid 28455095)
3. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350. (Pubitemid 27251137)
4. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-373. (Pubitemid 29102337)
5. Chicken DW, Keshtgar MR. The emerging role and implications of sentinel node biopsy in breast carcinoma. Hell J Nucl Med 2004;7:32-38. (Pubitemid 38679027)
6. Keshtgar MR, Ell PJ. Clinical role of sentinel-lymph-node biopsy in breast cancer. Lancet Oncol 2002;3:105-110. (Pubitemid 34162981)
7. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-581. (Pubitemid 30640103)
8. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-1726. (Pubitemid 29269240)
9. American Joint Committee on Cancer. Breast. In AJCC Cancer Staging Manual (6th edn). Springer: New York, 2002;257-282.
10. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunoh is to chemically detectable nonsentinel node metastasis. Ann Surg Oncol 1999;6:756-761. (Pubitemid 30013652)
11. Cady B. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 1997;66:7-10. (Pubitemid 27381472)
12. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-311.
13. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W et al. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 2003;98:690-696. (Pubitemid 36959263)
14. Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143-149. (Pubitemid 29022387)
15. Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku NN et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001;136:688-692. (Pubitemid 32525473)
16. Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 2000;66:574-578. (Pubitemid 30396249)
17. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001;182:316-320. (Pubitemid 33079078)
18. Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, van der Wall E, Licht J et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001;136:1059-1063. (Pubitemid 32982998)
19. Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001;8:145-149. (Pubitemid 32199411)
20. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Woo C et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 2001;136:563-568. (Pubitemid 32417547)
21. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-1384. (Pubitemid 32947820)
22. Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 2002;183:213-217. (Pubitemid 34273972)
23. Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 2002;28:623-626.
24. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 2002;184:302-306. (Pubitemid 35287346)
25. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF et al. Immunoh is to chemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098-1103. (Pubitemid 29115589)
26. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140-1151. (Pubitemid 40486808)
27. Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008;95:302-309.
28. Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008;8:66.
29. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843. (Pubitemid 13033817)
30. Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E et al. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 2008;112:523-531.
31. Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005;190:543-550. (Pubitemid 41306072)
32. Smidt ML, Kuster DM, van der Wilt GJ, Thunnissen FB, Van Zee KJ, Strobbe LJ. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005;12:1066-1072. (Pubitemid 41660683)
33. Alran S, De Rycke Y, Fourchotte V, Charitansky H, Laki F, Falcou MC et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007;14:2195-2201. (Pubitemid 47174905)
34. Dauphine CE, Haukoos JS, Vargas MP, Isaac NM, Khalkhali I, Vargas HI. Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2007;14:1014-1019.
35. Poirier E, Sideris L, Dubé P, Drolet P, Meterissian SH. Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the Canadian experience. Ann Surg Oncol 2008;15:2562-2567.
36. Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006;13:310-320. (Pubitemid 43255913)
37. Evrensel T, Johnson R, Ahrendt G, Bonaventura M, Falk JS, Keenan D et al. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer. Int J Clin Pract 2008;62:1379-1382.
38. Ponzone R, Maggiorotto F, Mariani L, Jacomuzzi ME, Magistris A, Mininanni P et al. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg 2007;193:686-692. (Pubitemid 46745283)
39. Kocsis L, Svébis M, Boross G, Sinkó M, Maráz R, Rajtár M et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 2004;70:1019-1024.
40. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-1197. (Pubitemid 27407219)
41. de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, Adang EM et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009;361:653-663.
42. Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 2008;26:1803-1809.
43. Leidenius MH, Vironen JH, Riihelä MS, Krogerus LA, Toivonen TS, von Smitten KA et al. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 2005;31:13-18. (Pubitemid 40103919)
44. van Iterson V, Leidenius M, Krogerus L, von Smitten K. Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 2003;82:39-45. (Pubitemid 37476018)
45. Fleming FJ, Kavanagh D, Crotty TB, Quinn CM, McDermott EW, O'Higgins N et al. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol 2004;57:73-76. (Pubitemid 38091315)
46. Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Garau X et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003;90:1354-1360. (Pubitemid 37421669)
47. Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J 2004;10:101-105. (Pubitemid 38375029)
48. Fournier K, Schiller A, Perry RR, Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 2004;239:859-863.
49. Cserni G, Burzykowski T, Vinh-Hung V, Kocsis L, Boross G, Sinkó M et al. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 2004;34:519-524. (Pubitemid 43115281)
50. Saidi RF, Dudrick PS, Remine SG, Mittal VK. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004;70:101-105.
51. Callejo IP, Brito JA, Bivar JW, Fernandes FJ, Faria JL, André MS et al. Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transl Oncol 2005;7:18-22.
52. Schrenk P, Konstantiniuk P, Wölfl S, Bogner S, Haid A, Nemes C et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 2005;92:707-713. (Pubitemid 40863189)
53. van der Loo EM, Hop WC, Tervoort MA, de Graaf PW. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth.] Ned Tijdschr Geneeskd 2004;148:938-943. (Pubitemid 38758124)
54. Scow JS, Degnim AC, Hoskin TL, Reynolds C, Boughey JC. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients. Cancer 2009;115:4064-4070.
55. Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005;12:654-659. (Pubitemid 41126095)
56. Smidt ML, Strobbe LJ, Groenewoud HM, der Wilt GJ, Van Zee KJ, Wobbes T. Can surgical oncologists reliably predict the likelihood for non-SLN metastases in breast cancer patients? Ann Surg Oncol 2007;14:615-620. (Pubitemid 46175307)